Current Situation and Management of Drug Shortage in Some Western Countries and Its Enlightenment to China
Sixu Dong , guiyu Lian
Asian Journal of Social Pharmacy ›› 2025, Vol. 20 ›› Issue (4) : 355 -362.
Objective To analyze the current situation of drug shortage in some western countries and their management strategies, and to put forward feasible suggestions for drug shortage management in China. Methods The methods of literature research and comparative study were used to collect policy information and related data from official government websites and news websites, then, the current situation and management of drug shortage in some western countries were compared and studied to summarize their effective experience in dealing with drug shortage. Results and Conclusion The current situation and influencing factors of drug shortage in these western countries are different, but the management system established to deal with drug shortage is good, including the support of policies and regulations, the early warning of monitoring platform and the construction of organizational system. Drawing lessons from their experience, China should strengthen cooperation and consultation among stakeholders and rationally allocate powers and responsibilities. The transparency of drug shortage data disclosure should be increased. The important role of pharmacists should be played to strengthen the management. Further optimizing the drug shortage management system in China can ensure the safety of drug supply.
drug shortage / shortage current situation / management
| [1] |
|
| [2] |
|
| [3] |
Food and |
| [4] |
Food and |
| [5] |
Food and |
| [6] |
European Medicines Agency. Good practices for industry for the prevention of human medicinal product shortages[EB/OL]. (2023-02-28)[2023-10-25]. https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/good-practices-industry-prevention-human-medicinalproduct- shortages_en.pdf. |
| [7] |
|
| [8] |
European Medicines Agency. Reflection Paper on Good Manufacturing Practice and Marketing Authorization Holders[EB/OL]. (2022-01-10)[2023-11-02]. https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-good-manufacturing-practice-marketingauthorisation-holders_en.pdf. |
| [9] |
|
| [10] |
|
| [11] |
National Health Commission. Notice on Printing and Distributing the National List of Drugs in Shortage (Trial)[EB/OL]. (2020-04-20)[2023-11-10]. https://www.gov.cn/zhengce/zhengceku/2020-04/24/content_5505943.htm. |
| [12] |
|
| [13] |
|
| [14] |
|
/
| 〈 |
|
〉 |